Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
START Study of rosuvastatin to improve coagulation profile after venous thrombosis
NL-OMON39948Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of rosuvastatin in Phlebothrombosis (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Change in coagulation profile after 28 days of rosuvastatin and Factor VIII difference. Started Dec 2012; status: active, not recruiting.
02
Drugs
rosuvastatin
03
Conditions
Phlebothrombosis
Beyond the preview
Go deeper on NL-OMON39948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39948.